Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Mise à jour : Il y a 5 ans
Référence : NCT01101009

Femme et Homme

  • | Pays :
  • Spain
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Comparison of the combination of amlodipine with an angiotensin receptor blocker or an angiotensin converting inhibitor, on central arterial blood pressure in patients with hypertension and additional risk factors. This is a randomised, double-blind, double-dummy, multicenter study. The duration of active treatment 24 weeks.


Critère d'inclusion

  • Hypertension

Liens